You are here
Generic Version of Zithromax Gains FDA Approval
"The addition of Azithromycin expands our anti-infective portfolio to 18 products and extends to 11 the number of different classes of anti-infectives APP offers," said Patrick Soon-Shiong, M.D., chairman and chief executive officer. "Azithromycin is the sixth multi-source product approval APP has received this year."
Azithromycin will be available from APP in 500 mg vials. The product is preservative-free and AP rated and each vial will include a bar code and latex-free vial stopper.
Azithromycin for Injection is indicated for the treatment of community-acquired pneumonia and pelvic inflammatory disease, when caused by susceptible microorganisms.
Source: American Pharmaceutical Partners, Inc.